Concentrix Corporation
CNXC
$61.67
$0.7851.29%
NASDAQ
| 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 11.31% | 21.66% | 35.20% | 44.09% | 33.62% |
| Total Other Revenue | -- | -67.75% | -28.38% | 15.05% | 39.55% |
| Total Revenue | 11.31% | 21.66% | 35.20% | 44.09% | 33.62% |
| Cost of Revenue | 12.14% | 22.12% | 36.00% | 43.68% | 32.93% |
| Gross Profit | 9.84% | 20.85% | 33.78% | 44.83% | 34.85% |
| SG&A Expenses | 4.12% | 11.71% | 30.16% | 56.12% | 40.15% |
| Depreciation & Amortization | 71.73% | 167.60% | 167.60% | 103.35% | 103.35% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.56% | 23.74% | 38.93% | 48.51% | 36.74% |
| Operating Income | -1.77% | 1.73% | 2.45% | 7.73% | 7.82% |
| Income Before Tax | -15.13% | -9.78% | -26.69% | -46.63% | -35.87% |
| Income Tax Expenses | -39.33% | -31.62% | -49.08% | -59.54% | -50.58% |
| Earnings from Continuing Operations | -8.05% | -3.13% | -19.95% | -41.30% | -29.76% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.05% | -3.13% | -19.95% | -41.30% | -29.68% |
| EBIT | -1.77% | 1.73% | 2.45% | 7.73% | 7.82% |
| EBITDA | 4.70% | 16.19% | 30.04% | 42.83% | 33.35% |
| EPS Basic | -15.82% | -17.75% | -35.72% | -54.00% | -40.39% |
| Normalized Basic EPS | -12.90% | -17.24% | -31.56% | -48.27% | -36.12% |
| EPS Diluted | -15.71% | -17.57% | -35.53% | -53.83% | -40.14% |
| Normalized Diluted EPS | -12.79% | -17.06% | -31.37% | -48.07% | -35.85% |
| Average Basic Shares Outstanding | 5.14% | 12.42% | 20.76% | 25.94% | 19.21% |
| Average Diluted Shares Outstanding | 5.03% | 12.22% | 20.46% | 25.48% | 18.70% |
| Dividend Per Share | 10.01% | 10.01% | 10.00% | 10.00% | 10.00% |
| Payout Ratio | 0.25% | 0.27% | 0.65% | 1.44% | 0.93% |